SENZAGEN AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8 SEK | +6.38% |
|
+25.39% | +9.89% |
| Mar. 25 | Senzagen Receives Follow-Up Order Worth SEK 0.8 Million from the Global Chemicals Leader | CI |
| Mar. 22 | SenzaGen AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 236.5 | 290 | 176.1 | 193.5 | - | - |
| Enterprise Value (EV) 1 | 236.5 | 290 | 160.1 | 185.5 | 184.5 | 169.5 |
| P/E ratio | -7.41 x | -11.7 x | -8 x | -12.9 x | -47.1 x | 19.5 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | 3.53 x | 2.86 x | 2.11 x | 1.6 x |
| EV / Revenue | - | - | 3.21 x | 2.75 x | 2.01 x | 1.4 x |
| EV / EBITDA | - | - | -22.7 x | -65.1 x | 17.9 x | 7.05 x |
| EV / FCF | - | - | -7.9 x | -18.6 x | - | 11.3 x |
| FCF Yield | - | - | -12.7% | -5.39% | - | 8.85% |
| Price to Book | - | - | 2.6 x | 3.59 x | 3.88 x | 3.24 x |
| Nbr of stocks (in thousands) | 23,648 | 24,065 | 24,188 | 24,188 | - | - |
| Reference price 2 | 10.00 | 12.05 | 7.280 | 8.000 | 8.000 | 8.000 |
| Announcement Date | 2/11/22 | 2/16/23 | 2/14/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | - | 49.87 | 67.55 | 91.65 | 121.1 |
| EBITDA 1 | - | - | -7.053 | -2.85 | 10.3 | 24.05 |
| EBIT 1 | - | - | -14.97 | -12.05 | 1.15 | 14.3 |
| Operating Margin | - | - | -30.01% | -17.84% | 1.25% | 11.81% |
| Earnings before Tax (EBT) 1 | - | - | -21.98 | -15 | -4 | 10 |
| Net income 1 | -31.35 | -24.91 | -22.1 | -15 | -4 | 10 |
| Net margin | - | - | -44.31% | -22.21% | -4.36% | 8.26% |
| EPS 2 | -1.350 | -1.030 | -0.9100 | -0.6200 | -0.1700 | 0.4100 |
| Free Cash Flow 1 | - | - | -20.26 | -10 | - | 15 |
| FCF margin | - | - | -40.63% | -14.8% | - | 12.39% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 62.37% |
| FCF Conversion (Net income) | - | - | - | - | - | 150% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 2/11/22 | 2/16/23 | 2/14/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 S1 | 2023 S1 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 19.92 | 23.59 | 26.28 | 14.6 | 18.3 | 16.1 | 24.1 |
| EBITDA 1 | -9.075 | - | - | -1.9 | -0.3 | -2.6 | 2.1 |
| EBIT 1 | -13.68 | -8.832 | -6.136 | -3.5 | -1.9 | -4.2 | 0.5 |
| Operating Margin | -68.64% | -37.44% | -23.35% | -23.97% | -10.38% | -26.09% | 2.07% |
| Earnings before Tax (EBT) | -13.44 | - | - | - | - | - | - |
| Net income | -13.5 | -12.3 | - | - | - | - | - |
| Net margin | -67.74% | -52.15% | - | - | - | - | - |
| EPS | - | -0.5100 | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 8/18/22 | 8/24/23 | 2/14/24 | - | - | - | - |
1SEK in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | - | 16 | 8 | 9 | 24 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | -20.3 | -10 | - | 15 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | 18.2% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share 2 | - | - | 2.800 | 2.230 | 2.060 | 2.470 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | - | 3.81 | 2 | 3 | 4 |
| Capex / Sales | - | - | 7.64% | 2.96% | 3.27% | 3.3% |
| Announcement Date | 2/11/22 | 2/16/23 | 2/14/24 | - | - | - |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +9.89% | 17.91M | |
| -16.10% | 11.41B | |
| +67.65% | 3.81B | |
| -14.31% | 2.16B | |
| -26.03% | 1.56B | |
| +36.95% | 1.19B | |
| -2.40% | 760M | |
| -19.00% | 506M | |
| -38.57% | 444M | |
| +13.72% | 339M |
- Stock Market
- Equities
- SENZA Stock
- Financials SenzaGen AB